4.3 Article

Differential effect of clopidogrel and aspirin on the release of BDNF from platelets

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 238, Issue 1-2, Pages 104-106

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2011.06.015

Keywords

Aspirin; Brain-derived neurotrophic factor; Clopidogrel; Platelet; Stroke

Funding

  1. University of Rostock
  2. Deutsche Forschungsgemeinschaft [LO 1145/2-2]

Ask authors/readers for more resources

Anti-platelet treatment is a key therapeutic intervention in patients with cerebrovascular diseases. However, there is no information on its impact on the release of Brain-derived neurotrophic factor (BDNF), which is stored in large amounts in human platelets and essential for neuronal protection and repair. Here, we show that a single oral dose of clopidogrel, but not aspirin, significantly reduced the release of BDNF from platelets in healthy volunteers. These data point, for the first time, to possible differential effects of anti-platelet regimens on neuronal function in patients with cerebrovascular disorders. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available